Financing channel feed – Endpoints News

Financing channel feed

Cosela maker's early employees aim to replicate 'blueprint' at a new biotech — with an old G1 asset

4 years ago

Attention biotech history: Ginkgo pours $700M+ on just 2 execs

4 years ago

Luca Santarelli's VectivBio bags $100M-plus in new funding from licensing pact, loan

4 years ago

Chasing Bristol Myers and Biogen/Denali, CNS biotech raises $100M in dash toward clinic

4 years ago

ConcertAI sings a unicorn tune as the FDA-partnered clinical trials software upstart expands

4 years ago

As shares skyrocket on Sanofi deal, IGM Biosciences looks to bag $200M

4 years ago

Another RA-backed biotech hits Nasdaq as public market stirs again after a bruising first quarter

4 years ago

Public biotechs raising funds? In this economy? A trio of companies brings $1.5B+ to battered sector after PhIII wins

4 years ago

Celsius aims to cool down inflammation with new investors and more pharma deals

4 years ago

Greg Verdine will have many new C-suite friends at fungus biotech LifeMine after GSK-fueled $175M round

4 years ago

In aiming to bypass CRISPR's delivery issues, one startup eyes the gene editing Spotlight

4 years ago

In year 3 of the pandemic, a new Covid-19 biotech takes flight with an antibody combo and Takeda's ex-vaccines chief at the helm

4 years ago

A new cell therapy startup from an immunotherapy pioneer raises $175M in KRAS quest

4 years ago

Going...going...gone. A small biotech throws in its IPO cards after market meltdown

4 years ago

Biotech upstart rides the upsurge in radiopharma R&D to $88M round with marquee investors

4 years ago

With its share price chewed to pieces, Nick Leschly's 2seventy scores $170M to help weather the storm

4 years ago

Back to the fundamentals: Frazier rolls out $1B fund to ramp up a new slate of biotech startups

4 years ago

Aiming to drug genetic modifiers, Roche-partnered biotech bags $31M to fuel a drive toward clinic

4 years ago

Morningside reveals its latest biotech effort, seeking to tackle wide range of inflammatory diseases

4 years ago

Blackstone leads $200M injection into data analysis software maker

4 years ago

Kurma scores $175M in first closing of biotech/healthtech fund — the VC's largest yet

4 years ago

Sherlock, Feng Zhang's CRISPR diagnostic outfit, grabs $80M to go beyond Covid-19

4 years ago

With investment from Alloy, Boston peptide manufacturer announces Series A

4 years ago

An AI biotech emerges from stealth promising drugs 'on demand.' What will that look like, and is it even possible?

4 years ago

First page Previous page 58 59 606162 63 64 Next page Last page